Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
430,339
-
Share change
-
+60,024
-
Total reported value
-
$1,533,736
-
Price per share
-
$4.16
-
Number of holders
-
13
-
Value change
-
+$180,546
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q4 2025
As of 31 Dec 2025,
GALECTIN THERAPEUTICS INC - COM NEW (GALT) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
430,339 shares.
The largest 10 holders included
Sovran Advisors, LLC, Traynor Capital Management, Inc., WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, CAHABA WEALTH MANAGEMENT, INC., Stratos Wealth Partners, LTD., STOCK YARDS BANK & TRUST CO, Blue Trust, Inc., CoreCap Advisors, LLC, Sound Income Strategies, LLC, and SIGNATUREFD, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.